These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4006813)

  • 41. Oxamniquine dosage in Malawi.
    Teesdale CH; Chitsulo L; Pugh RN
    East Afr Med J; 1984 Jan; 61(1):40-4. PubMed ID: 6745140
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapeutic evaluation of oxamniquine in schistosomiasis mansoni by the oogram method with biopsy of rectal mucosa].
    da Cunha AS
    Rev Inst Med Trop Sao Paulo; 1982; 24(2):88-94. PubMed ID: 6753086
    [No Abstract]   [Full Text] [Related]  

  • 43. [Schistosomiasis: clinical spectrum of the disease and response to oxamniquine treatment in chronic infections].
    García Goyco C; Torres Borges A
    Bol Asoc Med P R; 1982 Apr; 74(4):126-8. PubMed ID: 6960899
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of Eritrean schistosomiasis mansoni with oxamniquine.
    Pehrson PO; Bengtsson E
    Trans R Soc Trop Med Hyg; 1983; 77(2):282. PubMed ID: 6868118
    [No Abstract]   [Full Text] [Related]  

  • 45. Preliminary laboratory trials with oxamniquine as a prophylactic agent in schistosomiasis.
    Pellegrino J; Pereira LH; Mello RT
    Rev Inst Med Trop Sao Paulo; 1976; 18(2):97-101. PubMed ID: 1273410
    [No Abstract]   [Full Text] [Related]  

  • 46. [Schistosomiasis mansoni infestation treated with oxamnaquine].
    Shenker Y; Estrov Z; Nussinson E; Landau Z; Resnitzky P
    Harefuah; 1982 Nov; 103(9):199-200. PubMed ID: 7169187
    [No Abstract]   [Full Text] [Related]  

  • 47. [Action of oxamniquine on Schistosoma mansoni in mice experimentally infected with a strain from Kenya].
    Kohn A; Bruce J; Kinoti G; Mutahi WT; Coles G; Katz N
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():361. PubMed ID: 3151113
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter: Clinical trials with oxamniquine in the treatment of human mansonian schistosomiasis.
    Caetano da Silva L; Sette H; Fischer Chamone DA; Saez-Alquezar A
    Trans R Soc Trop Med Hyg; 1975; 69(2):288-9. PubMed ID: 1166499
    [No Abstract]   [Full Text] [Related]  

  • 49. Seizures and electroencephalograph changes associated with oxamniquine therapy.
    Keystone JS
    Am J Trop Med Hyg; 1978 Mar; 27(2 Pt 1):360-2. PubMed ID: 646029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Field trials with oxamniquine in a Schistosomiasis mansoni-endemic area.
    Katz N; Zicker F; Pereira JP
    Am J Trop Med Hyg; 1977 Mar; 26(2):234-7. PubMed ID: 848645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose-ranging clinical trial with oltipraz in schistosomiasis mansoni.
    Katz N; Rocha RS; Chaves A
    Rev Inst Med Trop Sao Paulo; 1982; 24(1):40-8. PubMed ID: 6750759
    [No Abstract]   [Full Text] [Related]  

  • 52. Spinal cord disease due to Schistosoma mansoni successfully treated with oxamniquine.
    Efthimiou J; Denning D
    Br Med J (Clin Res Ed); 1984 May; 288(6427):1343-4. PubMed ID: 6424851
    [No Abstract]   [Full Text] [Related]  

  • 53. The liver after oxamniquine treatment of schistosomiasis.
    Andrade ZA; dos Santos HA; Grimaud JA
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):37-40, 153-6. PubMed ID: 7455508
    [No Abstract]   [Full Text] [Related]  

  • 54. Schistosoma mansoni: the survival and reproductive status of mature infections in mice treated with oxamniquine.
    Popiel I; Erasmus DA
    J Helminthol; 1982 Sep; 56(3):257-61. PubMed ID: 7175165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current results in the clinical therapy of schistosomiasis mansoni.
    Katz N
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):8-17, 123-33. PubMed ID: 7006041
    [No Abstract]   [Full Text] [Related]  

  • 56. Quantitation of immunoglobulins in patients with schistosomiasis mansoni under chemotherapy.
    Mendes CM; Carvalho SA; Amato Neto V; Novo NF; Juliano Y; Mendes E
    Allergol Immunopathol (Madr); 1982; 10(2):105-8. PubMed ID: 7102486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Epidemiologic study of 2 foci of Schistosoma mansoni bilharziasis in Togo (Lama Kara and Kpalimé). Comparative efficacy of oltipraz (RP 35972)].
    Lapierre J; Amedome A; Tourte-Schaefer C; Agbo K; Kotor T; Faurant C; Ancelle T; Heyer F; Dupouy-Camet J
    Med Trop (Mars); 1984; 44(2):113-9. PubMed ID: 6482725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemoprophylactic properties of oxamniquine embonate in experimental schistosomiasis.
    Korolkovas A; Coelho PM; Oliveira e Rocha M; Pereira LH; Barbosa MA
    Rev Inst Med Trop Sao Paulo; 1980; 22(3):144-8. PubMed ID: 7466151
    [No Abstract]   [Full Text] [Related]  

  • 59. Oxamniquine in the prevention of bilharzial infection.
    Jewsbury JM
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):18-20. PubMed ID: 606372
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of oxamniquine therapy on kynurenine metabolism in liver homogenates of normal and S. mansoni infected mice.
    El-Toukhy MA; Ebied SA; El-Zoghby SM; Abd-Rabbo H; Hamouda N; El-Gohary YA
    Biochem Pharmacol; 1980 Sep; 29(18):2513-5. PubMed ID: 7426057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.